ROMANIELLO, DONATELLA
 Distribuzione geografica
Continente #
EU - Europa 1.008
NA - Nord America 235
AS - Asia 88
AF - Africa 2
Totale 1.333
Nazione #
FR - Francia 860
US - Stati Uniti d'America 230
CN - Cina 76
IT - Italia 42
IE - Irlanda 36
DE - Germania 35
BG - Bulgaria 11
GB - Regno Unito 10
AT - Austria 8
AE - Emirati Arabi Uniti 7
CA - Canada 5
NL - Olanda 4
SA - Arabia Saudita 4
CZ - Repubblica Ceca 1
FI - Finlandia 1
JP - Giappone 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 1.333
Città #
Paris 126
Ashburn 110
Beijing 38
Dublin 36
Bologna 29
Sofia 11
Bremen 9
Boardman 8
Frankfurt am Main 8
Vienna 8
Chicago 7
Fairfield 7
New York 7
Seattle 7
Forlì 6
Henderson 6
Santa Cruz 6
Southend 5
Buffalo 3
Fleming Island 3
Los Angeles 3
Phoenix 3
San Diego 3
Amsterdam 2
Cambridge 2
Civitanova Marche 2
Crugers 2
Montreal 2
Munich 2
Ottawa 2
Provo 2
Rimini 2
Woodbridge 2
Ann Arbor 1
Atlanta 1
Boulogne-Billancourt 1
Böblingen 1
Cesena 1
Changsha 1
Clearwater 1
Columbus 1
Cosenza 1
Dallas 1
Dongguan 1
Guangzhou 1
Gunzenhausen 1
Houston 1
Kirkland 1
Lappeenranta 1
Muizenberg 1
Nanjing 1
Norwalk 1
Nuremberg 1
Omaha 1
Padova 1
Rotterdam 1
San Francisco 1
Secaucus 1
Shanghai 1
Tokyo 1
Torcy 1
Toronto 1
Tunis 1
University Park 1
Wilmington 1
Ürümqi 1
Totale 502
Nome #
Senescence-associated reprogramming induced by interleukin-1 impairs response to EGFR neutralization, file e1dcb339-af7e-7715-e053-1705fe0a6cc9 842
ETS Proteins Bind with Glucocorticoid Receptors: Relevance for Treatment of Ewing Sarcoma, file e1dcb333-7d9b-7715-e053-1705fe0a6cc9 109
β-Caryophyllene Counteracts Chemoresistance Induced by Cigarette Smoke in Triple-Negative Breast Cancer MDA-MB-468 Cells, file c1dd2a4f-ae14-4de7-90dd-91c92dc12115 98
Senescence-associated reprogramming induced by interleukin-1 impairs response to EGFR neutralization, file e1dcb339-bf72-7715-e053-1705fe0a6cc9 40
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer, file daf66676-7c72-4ae8-aad0-62753fad4fdb 36
Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies, file e1dcb335-ba8f-7715-e053-1705fe0a6cc9 25
Senescence-associated reprogramming induced by interleukin-1 impairs response to EGFR neutralization, file e1dcb339-e69d-7715-e053-1705fe0a6cc9 25
Senescence-associated reprogramming induced by interleukin-1 impairs response to EGFR neutralization, file e1dcb339-df86-7715-e053-1705fe0a6cc9 19
IL-1 and senescence: Friends and foe of EGFR neutralization and immunotherapy, file 47f7078a-55a7-4d43-b181-852a8d166d99 17
Comparative analysis of the interaction between different flavonoids and pdia3, file 2b61c11e-e60f-40ae-9d0b-35dba19a1cbd 16
An oligoclonal antibody durably overcomes resistance of lung cancer to third-generation EGFR inhibitors, file e1dcb339-4e3c-7715-e053-1705fe0a6cc9 16
NRG1/ERBB3/ERBB2 Axis Triggers Anchorage-Independent Growth of Basal-like/Triple-Negative Breast Cancer Cells, file e1dcb339-ce59-7715-e053-1705fe0a6cc9 14
Extracellular Vesicles and Epidermal Growth Factor Receptor Activation: Interplay of Drivers in Cancer Progression, file aebe601e-ce31-4ae5-843d-d6ccb19efae0 12
Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models, file e1dcb339-0a1a-7715-e053-1705fe0a6cc9 12
Targeting HER3, a Catalytically Defective Receptor Tyrosine Kinase, Prevents Resistance of Lung Cancer to a Third-Generation EGFR Kinase Inhibitor, file e1dcb339-6c8b-7715-e053-1705fe0a6cc9 11
β-Hexachlorocyclohexane Drives Carcinogenesis in the Human Normal Bronchial Epithelium Cell Line BEAS-2B, file e1dcb339-0a18-7715-e053-1705fe0a6cc9 10
STAT3 post-translational modifications drive cellular signaling pathways in prostate cancer cells, file e1dcb339-4e3e-7715-e053-1705fe0a6cc9 9
Neuregulin 4 Boosts the Efficacy of Anti-ERBB2 Neutralizing Antibodies, file 64f16e7d-52b5-4113-9b9b-46de93f002ff 7
Aberrant MET activation impairs perinuclear actin cap organization with YAP1 cytosolic relocation, file 3cb30e67-dfed-42a6-b602-e39255abdfe9 6
Aberrant MET activation impairs perinuclear actin cap organization with YAP1 cytosolic relocation, file 671c4992-d787-4fd4-8e1a-54278e2073fc 4
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer, file 04105a15-9cb3-4264-9f8b-06761ed18ce0 3
Targeting HER3, a Catalytically Defective Receptor Tyrosine Kinase, Prevents Resistance of Lung Cancer to a Third-Generation EGFR Kinase Inhibitor, file 3e1305db-dfe0-49eb-993a-4ea65be55bda 3
An oligoclonal antibody durably overcomes resistance of lung cancer to third-generation EGFR inhibitors, file 9de04533-d1e9-4962-b149-54ed98ccf698 3
L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab, file b0486755-b7f6-48cc-9449-d49bada7c8c0 3
Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models, file 4f24c1d0-6844-47bf-a19d-37e3e15a4b6c 1
NRG1/ERBB3/ERBB2 Axis Triggers Anchorage-Independent Growth of Basal-like/Triple-Negative Breast Cancer Cells, file b168c98c-61d8-4576-8cc9-942c621f1e95 1
IL-1 Associated Post Senescence Reprogramming Impairs Response To EGFR Neutralization, file dabb68c4-e842-4c9f-92ef-9f8a92d8f721 1
A Combination of Approved Antibodies Overcomes Resistance of Lung Cancer to Osimertinib by Blocking Bypass Pathways, file e1dcb339-0a1b-7715-e053-1705fe0a6cc9 1
Totale 1.344
Categoria #
all - tutte 3.263
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.263


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202016 0 0 0 0 0 0 1 4 5 3 1 2
2020/202136 1 2 1 0 10 7 2 5 3 2 0 3
2021/202234 1 3 1 2 2 1 3 3 0 3 11 4
2022/2023143 1 3 10 20 18 5 3 10 40 9 17 7
2023/20241.115 9 7 8 17 5 527 155 323 40 23 1 0
Totale 1.344